COSCIENS Biopharma Inc.
Close on Oct 19, 2026
- Market cap
- $20.66M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
COSCIENS Biopharma has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements COSCIENS Biopharma filed with the SEC
Biopharma Inc. Completes Share Capital Amendment
EX-99.1 to Form 6-K
Biopharma Inc. Announces Details of Share Capital Amendment
EX-99.1 to Form 6-K
11.3 of National Instrument 51-102 – Continuous Disclosure Obligations
EX-99.2 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.2 to Form 6-K
EX-99.2 to Form 6-K
Biopharma Inc. Reports Q1 2026 Results
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
Discussion and Analysis of Financial Condition and Results of Operations
EX-99.2 to Form 6-K
650 De Maisonneuve Blvd., 7th Floor
EX-99.1 to Form 6-K
PROXY STATEMENT – SUBJECT TO COMPLETION, DATED APRIL 20, 2026
EX-99.1 to Form 6-K
Comments on Unusual Market Activity
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
De Maisonneuve Blvd., 7th Floor
EX-99.1 to Form 6-K
Biopharma Inc. Announces Leadership Change
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
Management’s Discussion and Analysis of Financial
EX-99.2 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
Discussion and Analysis of Financial Condition and Results of Operations
EX-99.2 to Form 6-K
Biopharma Announces Results of Virtual 2025 Meeting of Shareholders
EX-99.1 to Form 6-K
GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
EX-99.1 to Form 6-K
OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
EX-99.2 to Form 6-K
EX-99.3 to Form 6-K
EX-99.3 to Form 6-K
Biopharma Inc. Reconstitutes Board for Benefit of Shareholders
EX-99.1 to Form 6-K
650 De Maisonneuve Blvd., 7th Floor
EX-99.1 to Form 6-K
650 De Maisonneuve Blvd., 7th Floor
EX-99.2 to Form 6-K
OF EXECUTIVE COMPENSATION FOR THE YEAR ENDED DECEMBER 31, 2024
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
of Financial Condition and Results of Operations
EX-99.2 to Form 6-K